In our present investigation a new series of nucleoside derivatives (2-13) were synthesized from uridine (1) via only two step reactions by direct acylation method. Firstly, uridine (1) was treated with 4-t-butylbenzoyl chloride in pyridine at -5ºC and afforded the 5´-O-(4-tbutylbenzoyl)uridine derivative (2) in an excellent yield. In order to obtain newer products, the 5´-O-uridine derivative was further transformed to a series of 2´,3´-di-O-acyl derivatives (2-13) containing a wide variety of functionalities in a single molecular framework. The yields of the compounds were more than 80%. The synthesized titled compounds were characterized by their physical properties, FTIR (Fourier transform infrared spectroscopy), 1H-NMR (Nuclear magnetic resonance) spectroscopy and elemental analysis.
Introduction
Nucleotides and nucleosides are key compounds involved in major biological processes, such as nucleic acids and protein synthesis, cell signaling, enzyme regulation, and metabolism. Nucleosides and their analogues are of enormous importance. They are an established class of clinically useful medicinal agents possessing antiviral and anticancer activity; [1] [2] [3] [4] at the same time they are one class of compounds worthy of further investigation as antibacterial agents since some derivatives have shown moderate to good activity against specific bacterial strains. 5 The chemical modification of naturally occurring nucleoside and nucleotide structures is an important field in nucleic acid and medicinal chemistry. This has led to our interest in the search for new nucleoside derivatives that may be screened for a broad-spectrum of biological activities.
Uridine has crucial role in the pyrimidine metabolism of the brain. It supplies nervous tissue with the pyrimidine ring, and in turn, participates in a number of important metabolic pathways. Uridine and its nucleotide derivatives may also have an additional role in the function of the central nervous system as signaling molecules. 6 There are established signaling molecules in the brain, such as amino acids, and adenosine, which are also available in large pools as metabolites. 7, 8 Nucleosides and carbohydrates can also be acylated selectively using a number of suitable methods to give newer derivatives, some of which show effective biological activity. Selective acylation is very important in the field of nucleoside chemistry because of its usefulness for the synthesis of biologically active products. During the last few years, many workers have investigated selective acylation of hydroxyl groups of the carbohydrate moieties of nucleosides and nucleotides using various methods. 9, 10 Different methods for acylation of carbohydrates and nucleosides have so far been developed and employed successfully. 11, 12 Of these, a direct method has been found to be the most encouraging method for acylation of carbohydrates and nucleosides. 13 It was found from the literature survey that nitrogen, sulphur and halogen containing heterocyclic compounds showed marked antimicrobial activities.
14 When heterocyclic part become attached to carbohydrates, 15 their efficiency to inhibit bacteria or fungi sharply increased. A large number of biologically active compounds also possess aromatic, heteroaromatic and acyl substituents. 15 It is also known that if an active nucleus is linked to another active nucleus, the resulting molecule may possess greater potential for biological activity. [15] [16] [17] From our previous works we also observed that in many cases the combination of two or more acyl substituents in a single molecular framework enhances the biological profile many fold comparing to their parent nuclei. [18] [19] [20] [21] [22] [23] [24] Encouraged by our own findings and previous reports, we synthesized a series of nucleoside i.e., uridine derivatives deliberately incorporating a wide variety of probable biologically active components to the ribose moiety. We report here the synthetic part of the work whereas the biological evaluation part will be the subject of a forthcoming communication.
Results and Discussion

Chemistry and spectral characterization
The main aim of the research work presented in this paper was to carry out selective 4-tbutylbenzoylation of uridine (1) with 4-t-butylbenzoyl chloride using the direct method. A series of derivatives of the resulting 4-t-butylbenzoylation product were prepared using non-traditional eleven acylating agents (Schemes 1 and 2) . The structure of all acylated products were ascertained by analyzing their FTIR, 1 H-NMR spectra, elemental and physicochemical data ( Table 1) . The 4-tbutylbenzoate 2 and its derivatives were employed as test chemicals for antimicrobial studies and the results will be reported later. Our initial effort was to carry out the reaction of uridine (1) with 1.1 molar amount of 4-tbutylbenzoyl chloride in dry pyridine at -5 0 C. Conventional work-up procedure, followed by silica gel column chromatographic separation, we were able to purify 4-t-butylbenzoyl derivative (2) as needless. The IR spectrum of compound 2 showed absorption bands at: 1785 cm Further support for the structure of the 4-t-butylbenzoate 2 was achieved by the conversion to acetyl derivative 3 and its identification. Thus, acetylation of compound 2 with acetic anhydride in pyridine, followed by usual procedure and purification, provided the di-O-acetyl derivative (3) as crystalline solid. Recrystallization from ethyl acetate-hexane gave the pure compound (3) H-NMR spectra of the acetyl derivative was assigned as 2 Additional support for the structure accorded to compound 2 was achieved by preparation and identification of decanoyl derivative (6) in good yield. The infrared spectrum of compound 6 showed the absorption band at 1760 cm -1 due to -CO stretching. The 1 H-NMR spectrum of compound 6 displayed two four-proton multiplets at δ 2.37 {2×CH3(CH2)7CH2CO-} and 1.66 {2×CH3(CH2)6CH2CH2CO-}, a twenty four-proton multiplet at δ 1.24 {2×CH3(CH2)6(CH2)2CO-} and a six-proton multiplet at δ 0.88 {2×CH3(CH2)8CO-} showing the attachment of two decanoyl groups in the molecule. By similar procedure, the lauroyl derivative (7) was obtained as semi-solid. The IR spectrum displayed absorption bands at 1758 cm Final confirmation of the structure of the compound 2 was provided by preparation of its 2,6-dichlorobenzoyl derivative (13) . Reaction of compound 2 with 2,6-dichlorobenzoyl chloride in pyridine, as usual procedure gave the dichlorobenzoyl derivative (13) as pasty mass. The IR spectrum of this compound showed absorption band at 1778 cm Thus, selective acylation of uridine (1) with a number of acylating agents by applying the direct method was unique in that all the reactions provided a single mono-substitution product in reasonably high yield. These acylation products and their derivatives may further be utilized as probable starting materials for the synthesis of newer derivatives. These acylating agents, though seldom used by other workers for selective acylation of nucleosides, were found to be very encouraging in terms of high selectivity and good yields. All these substitution products were subjected to antimicrobial evaluation studies and the results will be reported later in our forthcoming paper.
Conclusions
In this article, we have presented the initial efforts to synthesize novel nucleoside derivatives obtained from the direct acylation method. This method demonstrates a very simple, rapid and efficient method for the synthesis. The synthesized compounds 2´,3´-di-O-acetyl-5´-O-(4-tbutylbenzoyl)uridine (3) and 5'-O-(4-t-butylbenzoyl)-2´,3´-di-O-hexanoyluridine (5) were found to be encouraging in terms of high selectivity and excellent yields as 92% and 89%, respectively. 1 H-NMR spectra.
Experimental
Materials and methods
Uridine and all reagents used were commercially available (Aldrich and Merck) and were used as received, unless otherwise specified. 1 H-NMR (400 MHz) spectra were recorded for solutions in CDCl3 using TMS as internal standard with a Bruker DPX-400 spectrometer. Evaporations were carried out under reduced pressure using VV-1 type vacuum rotary evaporator (Germany) with a bath temperature below 40 o C. Melting points were determined on an electro-thermal melting point apparatus (England) and are uncorrected. Column chromatography was performed with silica gel G60. Thin layer chromatography (t.l.c) was performed on Kieselgel GF254 and spots were detected by spraying the plates with 1% H2SO4 and heating at 150-200 o C until coloration took place. The reaction pathways have been summarized in Schemes 1 and 2.
Synthesis
To a cooled (-5ºC) and stirred solution of uridine (1) (3g, 12.3 mmol) in anhydrous pyridine (36 ml) was treated with 4-t-butylbenzoyl chloride (2.55 ml, 13.01 mmol) and stirring was continued at this temperature for 7 hrs. The progress of the reaction was checked by t.l.c (methanol-chloroform, 1:12) which indicated full conversion of the starting material into a single product (Rf = 0.50). A few pieces of ice were added to the reaction and flask with constant shaking and then contents extracted with chloroform. The chloroform layer was washed successively with dilute hydrochloric acid, saturated aqueous sodium hydrogen carbonate and water. The organic layer was concentrated with dried MgSO4 and then the residue was subjected to silica gel column chromatographic purification (methanolchloroform, 1:12) to furnish the 4-t-butylbenzoyl derivative (2) (243 mg, 48%) yield as a solid. Recrystallization from ethyl acetate-n-hexane gave the 5´-O-(4-t-butylbenzoyl)uridine (2) as needles mp. 159-161°C. (2) . Colorless crystalline solid, FTIR (CHCl3, ν cm 
5´-O-(4-t-butylbenzoyl)uridine
General procedure for the synthesis of 5´-O-(4-t-butylbenzoyl)uridine derivatives (3-13)
A cooled (0°C) and stirred solution of the 5´-O-(4-t-butylbenzoyl)uridine (2) (50 mg, 0.13 mmol) in dry pyridine (3 ml) was separately treated with acetic anhydride (0.046 ml, 0.39 mmol), pentanoyl chloride (0.057 ml, 0.43 mmol), hexanoyl chloride (0.065 ml, 0.54 mmol), decanoyl chloride (0.116 ml, 0.52 mmol), lauroyl chloride (0.14 ml, 0.39 mmol), myristoyl chloride (0.195 ml, 0.67 mmol), palmitoyl chloride (0.15 ml, 0.59 mmol), methanesulfonyl chloride (0.165 ml, 0.73 mmol), 3-chlorobenzoyl chloride (0.1 ml, 0.017 mmol), 4-chlorobenzoyl chloride (0.13 ml, 0.018 mmol) and 2,6-di-chlorobenzoyl chloride (0.14 ml, 0.019 mmol), respectively and stirring was continued at 0°C for 6-7.5 hrs. The progress of the reaction was monitored by t.l.c., which indicated formation of a single product. The reaction mixture was then allowed to stand at room temperature overnight. Excess reagent was decomposed by addition of a few pieces of ice to the flask. The contents in the flask were extracted with chloroform (3×10 ml). The organic layer was washed with dilute hydrochloric acid, followed by saturated aqueous sodium hydrogen carbonate solution and distilled water. The organic layer was dried magnesium sulfate, filtered and concentrated to dryness. The resulting syrupy residue was passed through a silica gel column and eluted with methanol-chloroform and ethyl acetate-n-hexane at different ratio (Table 1) (6) . White syrup, FTIR (CHCl3, ν cm 1H, m, H-4´), 2.33 {4H, m, 2×CH3(CH2)11CH2CO-}, 1.29 {9H, s, (CH3)3C-}, 1 .27 {44H, m, 2×CH3(CH2)11CH2CO-}, 0.88 {6H, m, 2×CH3(CH2)12CO-}. Anal. Calcd for C48H76N2O9 %: C, 69.87; H, 9.28; Found: C, 69.91; H, 9.30. (9) . White crystalline solid (ethyl acetatehexane), FTIR (CHCl3, ν cm (10) . White needles (ethyl acetatehexane), FTIR (CHCl3, ν cm
5´-O-(4-t-butylbenzoyl)-2,´3´-di-O-decanoyluridine
5'-O-(4-t-butylbenzoyl)-2´,3´-di-O-palmitoyluridine
5'-O-(4-t-butylbenzoyl)-2´,3´-di-O-methensulfonyluridine
